Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fortinn Strong
- Development stage
- Unknown
- Lead developer
- INNventa Pharm
- Modality
- Peptides
- Administration
- Oral
01
Overview
Fortinn Strong is a nutraceutical supplement developed by INNventa Pharm, specifically formulated to support joint health and the regeneration of articular cartilage. The product contains a high concentration of bioactive collagen peptides (specifically Fortigel), which are optimized to stimulate the metabolic activity of chondrocytes in the joints. By promoting the synthesis of extracellular matrix components such as Type II collagen and proteoglycans, Fortinn Strong helps to restore cartilage density and improve joint mobility. The "Strong" formulation typically provides a higher dosage of collagen peptides compared to the standard version and is often enriched with Vitamin C to serve as an essential cofactor for collagen synthesis. It is marketed as an oral supplement for individuals suffering from osteoarthritis, chronic joint pain, or those recovering from physical injuries affecting the connective tissues.
- Brand names
- Fortinn Strong
02
Targets
ACAN (Aggrecan core protein)COL2 (Type II Collagen)
Beyond the preview
Go deeper on Fortinn Strong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fortinn Strong.